What is the Full Form of ANDA?
ANDA stands for Abbreviated New Drug Application, a regulatory application used to seek approval for a generic drug based on an already approved brand-name medicine.
ANDA Meaning in Medicine
ANDA means a shortened drug approval application used for generic medicines. It is not used for discovering or approving a completely new drug. It is used when a manufacturer wants approval for a generic version of a medicine that has already been approved by the drug regulator.
Generic Drug Approval Use
ANDA is used in the pharmaceutical industry for generic drug approval. A generic medicine is checked against an approved reference medicine so the regulator can decide whether it can be marketed as an alternative version of the original brand-name drug.
Abbreviated Application Purpose
ANDA is called abbreviated because the applicant usually does not need to repeat all original clinical studies completed for the brand-name medicine. The application depends on existing approval knowledge and focuses on showing that the proposed generic drug matches the approved medicine in required ways.
Approved Brand Drug Basis
An ANDA depends on a medicine that has already been approved. The proposed generic drug is compared with that approved medicine so the regulator can check whether both products are close enough in identity, use, quality, and expected performance.
ANDA and Generic Medicines
ANDA is closely connected with generic medicines because it is the approval route used for many generic drug products. The application helps show that the generic version is not a new medicine from the beginning, but a comparable version of an existing approved medicine.
ANDA and NDA Difference
ANDA is used for generic drug approval, while NDA is used for new drug approval with original safety and effectiveness evidence. See the full ANDA vs NDA comparison for a detailed breakdown of how these two approval routes differ.
Simple ANDA Example
If a brand-name tablet is already approved, another company may develop a generic version of the same tablet. To sell that generic version, the company files an ANDA to show that the proposed medicine is based on the approved drug and meets the required generic approval standards.
Related ANDA Topics
Bioequivalence in ANDA covers how a generic drug proves comparable body performance by showing similar rate and amount of active ingredient delivery. ANDA vs NDA explains how the generic approval route differs from the new drug approval route. ANDA requirements cover the eligibility conditions and evidence standards a generic drug must satisfy. ANDA submission covers the formal filing package a manufacturer sends to the regulator. ANDA review covers the regulatory evaluation stage where the submitted application is checked before an approval decision is made.
Related Pharma Terms
Common terms connected with ANDA include NDA, FDA, generic drug, reference listed drug, active ingredient, bioequivalence, labeling, and manufacturing quality. These terms explain the approval route, comparison drug, performance proof, product identity, and quality controls used in generic medicine approval.